Providing clinical leaders with the tools necessary to start and maintain patients on effective treatment for opioid use disorder
Patients with opioid use disorder are frequently hospitalized with complications from the condition, yet don’t receive treatment for their underlying disease. This is a missed opportunity that leaves patients at high risk of future overdose. These hospitalizations are an ideal opportunity to start effective medication treatment for addiction and connect patients to ongoing outpatient services.
Two key treatments for opioid use disorder — buprenorphine and methadone — have been proven to cut overdose rates by two-thirds, lower HIV infections, and reduce criminal behavior. As many as 70% of patients are still in treatment after one year, compared to 6% of patients receiving medication-free treatment. However, when patients being treated with buprenorphine or methadone are hospitalized, these medications are often discontinued, increasing their risk of relapse.
This program provides clinical leaders with the tools they need to start and maintain patients on buprenorphine or methadone during hospitalizations for any condition, be it medical, surgical, or obstetric. Specialists from the University of California, San Francisco (UCSF) provide a suite of supports: coaching, toolkits, protocols, monographs for pharmacy and therapeutics committees, webinars, and onsite presentations.
Connect with us
Use the form below to contact us to receive additional support to increase access to care for patients with opioid use disorder. Please be as detailed as possible in describing what stage you are at and how we might best assist your goals. Include the name and location of your specific hospital or organization along with any specific requests.